secwatch / observer
8-K filed November 2, 2022, 7:59 PM ET ticker INGN CIK 0001294133
earnings confidence high sentiment negative materiality 0.75

Inogen Q3 revenue rises 13.2% to $105.4M but swings to GAAP net loss of $9.5M

Inogen Inc

2022-Q3 EPS reported -$1.19 revenue$289,150,000

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Inogen Inc reported the quarter ended September 30, 2022 results: revenue $105.4 million, net income $9.5 million.

Period
the quarter ended September 30, 2022
Revenue
$105.4 million
Net income
$9.5 million
Result
reported results
Exact text from the filing
Third quarter total revenue increased 13.2% to $105.4 million from $93.1 million in the third quarter of 2021, primarily driven by higher domestic business-to-business sales, as well as continued strength in the rental channel, partially offset by lower international business-to-business and direct-to-consumer sales. Total gross margin was 40.6% in the third quarter of 2022 versus 51.2% in the comparative period in 2021. The decline was driven primarily by increased material costs and unfavorable sales channel mix, partially offset by higher average selling prices. Total operating expense for the quarter was $53.1 million compared to $41.3 million in the third quarter of 2021, representing an increase of 28.5%. The increased spend was primarily due to ongoing strategic investments required to position the Company for long-term sustainable growth. Additionally, there was a non-cash decrease in the benefit from the change in fair value of the New Aera earnout liability. GAAP net loss for
View on SEC.gov
Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Inogen Inc: Amended and restated bylaws to revise director nomination procedures, stockholder meeting provisions, forum selection, board action by written consent, indemnification, and other updates to conform to Delaware law (effective 2022-10-27).

Change
bylaw amendment
Effective
2022-10-27
Exact text from the filing
On October 27, 2022, the Board of Directors (the “Board”) of the Company, acting upon the recommendation of the Nominating and Governance Committee of the Board, amended and restated the Company’s amended and restated bylaws, effective immediately.
View on SEC.gov

Browse all earnings releases →

Inogen Inc filing history →

Source: SEC EDGAR
accession 0000950170-22-020979
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.